Pricing Log in Create free account

Perspective Therapeutics, Inc. (CATX) vs Pulmonx Corporation (LUNG)

Perspective Therapeutics, Inc. and Pulmonx Corporation are both Medical Devices companies. Pulmonx Corporation is the larger, with a market value of $111.5M against $90.0M — 1.2× the size. Pulmonx Corporation grew revenue faster over the last twelve months: −3.15% against −66.9%. Pulmonx Corporation has the higher net margin (−47.9% vs −28,468.0%) and the lower return on invested capital (−129.9% vs −88.4%). Across the 18 metrics below, Pulmonx Corporation leads on 10 and Perspective Therapeutics, Inc. on 8.

Valuation

Metric CATX LUNG Medical Devices median
P/E n/m n/m 25.58
P/S 235.99 1.22 2.54
P/B 0.30 3.17 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA 1.13 n/m 11.51
EV/Sales (339.40) 1.05 2.72
Earnings yield (165.86%) (40.41%) (12.82%)
Free cash flow yield (125.56%) (23.63%) (8.18%)

Profitability

Metric CATX LUNG Medical Devices median
Gross margin 100.00% 77.42% 57.76%
Operating margin (30,619.07%) (44.39%) (15.07%)
Net margin (28,467.97%) (47.93%) (14.45%)
Free cash flow margin (29,630.07%) (28.85%) (3.88%)
Return on equity (39.50%) (90.31%) (10.35%)
Return on assets (33.14%) (34.25%) (17.26%)
Return on invested capital (88.41%) (129.86%) (5.27%)

Growth

Metric CATX LUNG Medical Devices median
Revenue growth (TTM) (66.88%) (3.15%) 10.41%
EPS growth (last fiscal year) (13.82%) 7.64% 28.17%
Revenue growth, 5-year CAGR (38.04%) 22.55% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CATX LUNG Medical Devices median
Debt to equity 0.00 1.10 0.04
Current ratio 6.61 4.05 2.74
Net debt to EBITDA 1.27 0.62 0.54

Dividend

Metric CATX LUNG Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric CATX LUNG Medical Devices median
Market cap 89.99m 111.49m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack